High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays

Søren Buus; Johan Rockberg; Björn Forsström; Peter Nilsson; Mathias Uhlen; Claus Schafer-Nielsen

doi:10.1074/mcp.M112.020800

High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays

Søren Buus, Johan Rockberg, Björn Forsström, Peter Nilsson, Mathias Uhlen, Claus Schafer-Nielsen

98 Citationer (Scopus)

Abstract

Antibodies empower numerous important scientific, clinical, diagnostic, and industrial applications. Ideally, the epitope(s) targeted by an antibody should be identified and characterized, thereby establishing antibody reactivity, highlighting possible cross-reactivities, and perhaps even warning against unwanted (e.g. autoimmune) reactivities. Antibodies target proteins as either conformational or linear epitopes. The latter are typically probed with peptides, but the cost of peptide screening programs tends to prohibit comprehensive specificity analysis. To perform high-throughput, high-resolution mapping of linear antibody epitopes, we have used ultrahigh-density peptide microarrays generating several hundred thousand different peptides per array. Using exhaustive length and substitution analysis, we have successfully examined the specificity of a panel of polyclonal antibodies raised against linear epitopes of the human proteome and obtained very detailed descriptions of the involved specificities. The epitopes identified ranged from 4 to 12 amino acids in size. In general, the antibodies were of exquisite specificity, frequently disallowing even single conservative substitutions. In several cases, multiple distinct epitopes could be identified for the same target protein, suggesting an efficient approach to the generation of paired antibodies. Two alternative epitope mapping approaches identified similar, although not necessarily identical, epitopes. These results show that ultrahigh-density peptide microarrays can be used for linear epitope mapping. With an upper theoretical limit of 2,000,000 individual peptides per array, these peptide microarrays may even be used for a systematic validation of antibodies at the proteomic level.

Originalsprog	Engelsk
Tidsskrift	Molecular and Cellular Proteomics
Vol/bind	11
Udgave nummer	12
Sider (fra-til)	1790-1800
Antal sider	11
ISSN	1535-9476
DOI	https://doi.org/10.1074/mcp.M112.020800
Status	Udgivet - dec. 2012

Adgang til dokumentet

10.1074/mcp.M112.020800

Citationsformater

@article{5a76f99465184b84ae8488246116d807,

title = "High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays",

abstract = "Antibodies empower numerous important scientific, clinical, diagnostic, and industrial applications. Ideally, the epitope(s) targeted by an antibody should be identified and characterized, thereby establishing antibody reactivity, highlighting possible cross-reactivities, and perhaps even warning against unwanted (e.g. autoimmune) reactivities. Antibodies target proteins as either conformational or linear epitopes. The latter are typically probed with peptides, but the cost of peptide screening programs tends to prohibit comprehensive specificity analysis. To perform high-throughput, high-resolution mapping of linear antibody epitopes, we have used ultrahigh-density peptide microarrays generating several hundred thousand different peptides per array. Using exhaustive length and substitution analysis, we have successfully examined the specificity of a panel of polyclonal antibodies raised against linear epitopes of the human proteome and obtained very detailed descriptions of the involved specificities. The epitopes identified ranged from 4 to 12 amino acids in size. In general, the antibodies were of exquisite specificity, frequently disallowing even single conservative substitutions. In several cases, multiple distinct epitopes could be identified for the same target protein, suggesting an efficient approach to the generation of paired antibodies. Two alternative epitope mapping approaches identified similar, although not necessarily identical, epitopes. These results show that ultrahigh-density peptide microarrays can be used for linear epitope mapping. With an upper theoretical limit of 2,000,000 individual peptides per array, these peptide microarrays may even be used for a systematic validation of antibodies at the proteomic level.",

keywords = "Amino Acid Sequence, Animals, Antibodies, Epitope Mapping, Epitopes, Humans, Peptides, Protein Array Analysis, Proteome, Rabbits",

author = "S{\o}ren Buus and Johan Rockberg and Bj{\"o}rn Forsstr{\"o}m and Peter Nilsson and Mathias Uhlen and Claus Schafer-Nielsen",

year = "2012",

month = dec,

doi = "10.1074/mcp.M112.020800",

language = "English",

volume = "11",

pages = "1790--1800",

journal = "Molecular and Cellular Proteomics",

issn = "1535-9476",

publisher = "American Society for Biochemistry and Molecular Biology",

number = "12",

}

TY - JOUR

T1 - High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays

AU - Buus, Søren

AU - Rockberg, Johan

AU - Forsström, Björn

AU - Nilsson, Peter

AU - Uhlen, Mathias

AU - Schafer-Nielsen, Claus

PY - 2012/12

Y1 - 2012/12

N2 - Antibodies empower numerous important scientific, clinical, diagnostic, and industrial applications. Ideally, the epitope(s) targeted by an antibody should be identified and characterized, thereby establishing antibody reactivity, highlighting possible cross-reactivities, and perhaps even warning against unwanted (e.g. autoimmune) reactivities. Antibodies target proteins as either conformational or linear epitopes. The latter are typically probed with peptides, but the cost of peptide screening programs tends to prohibit comprehensive specificity analysis. To perform high-throughput, high-resolution mapping of linear antibody epitopes, we have used ultrahigh-density peptide microarrays generating several hundred thousand different peptides per array. Using exhaustive length and substitution analysis, we have successfully examined the specificity of a panel of polyclonal antibodies raised against linear epitopes of the human proteome and obtained very detailed descriptions of the involved specificities. The epitopes identified ranged from 4 to 12 amino acids in size. In general, the antibodies were of exquisite specificity, frequently disallowing even single conservative substitutions. In several cases, multiple distinct epitopes could be identified for the same target protein, suggesting an efficient approach to the generation of paired antibodies. Two alternative epitope mapping approaches identified similar, although not necessarily identical, epitopes. These results show that ultrahigh-density peptide microarrays can be used for linear epitope mapping. With an upper theoretical limit of 2,000,000 individual peptides per array, these peptide microarrays may even be used for a systematic validation of antibodies at the proteomic level.

AB - Antibodies empower numerous important scientific, clinical, diagnostic, and industrial applications. Ideally, the epitope(s) targeted by an antibody should be identified and characterized, thereby establishing antibody reactivity, highlighting possible cross-reactivities, and perhaps even warning against unwanted (e.g. autoimmune) reactivities. Antibodies target proteins as either conformational or linear epitopes. The latter are typically probed with peptides, but the cost of peptide screening programs tends to prohibit comprehensive specificity analysis. To perform high-throughput, high-resolution mapping of linear antibody epitopes, we have used ultrahigh-density peptide microarrays generating several hundred thousand different peptides per array. Using exhaustive length and substitution analysis, we have successfully examined the specificity of a panel of polyclonal antibodies raised against linear epitopes of the human proteome and obtained very detailed descriptions of the involved specificities. The epitopes identified ranged from 4 to 12 amino acids in size. In general, the antibodies were of exquisite specificity, frequently disallowing even single conservative substitutions. In several cases, multiple distinct epitopes could be identified for the same target protein, suggesting an efficient approach to the generation of paired antibodies. Two alternative epitope mapping approaches identified similar, although not necessarily identical, epitopes. These results show that ultrahigh-density peptide microarrays can be used for linear epitope mapping. With an upper theoretical limit of 2,000,000 individual peptides per array, these peptide microarrays may even be used for a systematic validation of antibodies at the proteomic level.

KW - Amino Acid Sequence

KW - Animals

KW - Antibodies

KW - Epitope Mapping

KW - Epitopes

KW - Humans

KW - Peptides

KW - Protein Array Analysis

KW - Proteome

KW - Rabbits

U2 - 10.1074/mcp.M112.020800

DO - 10.1074/mcp.M112.020800

M3 - Journal article

C2 - 22984286

SN - 1535-9476

VL - 11

SP - 1790

EP - 1800

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

IS - 12

ER -

High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater